Clinical Trials Directory

Trials / Unknown

UnknownNCT03182114

Supine Versus Left Lateral Tilted Position During Cesarean Delivery

Hemodynamic Effects of Supine Position Versus Left Lateral Tilted Position During Cesarean Delivery: a Randomized Controlled Trial.

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
450 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

In this study, we will investigate the effect of left lateral tiling performed after spinal block on maternal hemodynamics compared to ordinary supine position

Detailed description

Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Aortocaval compression is one of the theoretical mechanisms precipitating for post-spinal hypotension (PSH) for CD. Positioning of the patients in the left lateral tilted position after preforming spinal block was frequently considered a standard protocol for minimizing aortocaval compression and improve maternal hemodynamics during CD; however, the latest Cochrane database review reported that there is no adequate evidence to support any positioning protocol for prevention of PSH. Moreover, a recent study was conducted in full term pregnant women reporting no improvement in cardiac output with left lateral tilting. In this study, the effect of left lateral tiling performed after spinal block on maternal hemodynamics will be compared to ordinary supine position.

Conditions

Interventions

TypeNameDescription
OTHERsupine positionthe patient will be placed in regular supine position after spinal anesthesia
OTHERleft lateral tilted positionthe patient will be placed in left lateral tilted position after spinal anesthesia
DRUGBupivacaineThe patient will receive 10 mg Bupivacaine for spinal anesthesia

Timeline

Start date
2017-06-12
Primary completion
2019-01-15
Completion
2019-01-20
First posted
2017-06-09
Last updated
2018-07-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03182114. Inclusion in this directory is not an endorsement.